BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15694204)

  • 1. Genetic alterations in the mouse myelin basic proteins result in a range of dysmyelinating disorders.
    Jacobs EC
    J Neurol Sci; 2005 Feb; 228(2):195-7. PubMed ID: 15694204
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT; Wu C; Fecenko-Tacka K
    J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channel density in hypomyelinated brain increased by myelin basic protein gene deletion.
    Noebels JL; Marcom PK; Jalilian-Tehrani MH
    Nature; 1991 Aug; 352(6334):431-4. PubMed ID: 1713650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
    McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
    Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro myelination by oligodendrocyte precursor cells transfected with the neurotrophin-3 gene.
    Rubio N; Rodriguez R; Arevalo MA
    Glia; 2004 Jul; 47(1):78-87. PubMed ID: 15139015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
    Padovani-Claudio DA; Liu L; Ransohoff RM; Miller RH
    Glia; 2006 Oct; 54(5):471-83. PubMed ID: 16886211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelination and motor coordination are increased in transferrin transgenic mice.
    Saleh MC; Espinosa de los Monteros A; de Arriba Zerpa GA; Fontaine I; Piaud O; Djordjijevic D; Baroukh N; Garcia Otin AL; Ortiz E; Lewis S; Fiette L; Santambrogio P; Belzung C; Connor JR; de Vellis J; Pasquini JM; Zakin MM; Baron B; Guillou F
    J Neurosci Res; 2003 Jun; 72(5):587-94. PubMed ID: 12749023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olig gene function in CNS development and disease.
    Ligon KL; Fancy SP; Franklin RJ; Rowitch DH
    Glia; 2006 Jul; 54(1):1-10. PubMed ID: 16652341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin basic protein functions as a microtubule stabilizing protein in differentiated oligodendrocytes.
    Galiano MR; Andrieux A; Deloulme JC; Bosc C; Schweitzer A; Job D; Hallak ME
    J Neurosci Res; 2006 Aug; 84(3):534-41. PubMed ID: 16773649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myelin basic protein gene: a prototype for combinatorial mammalian transcriptional regulation.
    Farhadi HF; Peterson AC
    Adv Neurol; 2006; 98():65-76. PubMed ID: 16400827
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelin basic protein and myelinogenesis: morphometric analysis of normal, mutant and transgenic central nervous system.
    Shine HD; Readhead C; Popko B; Hood L; Sidman RL
    Prog Clin Biol Res; 1990; 336():81-92. PubMed ID: 1691511
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of protease M/neurosin in myelination during experimental demyelination and remyelination.
    Bando Y; Ito S; Nagai Y; Terayama R; Kishibe M; Jiang YP; Mitrovic B; Takahashi T; Yoshida S
    Neurosci Lett; 2006 Sep; 405(3):175-80. PubMed ID: 16890353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the murine mutation myelin deficient.
    Popko B
    Epilepsy Res Suppl; 1991; 4():275-82. PubMed ID: 1726136
    [No Abstract]   [Full Text] [Related]  

  • 15. Insertional mutagenesis inducing hypomyelination in transgenic mice.
    Orian JM; Mitchell AW; Marshman WE; Webb GC; Ayers MM; Grail D; Ford JH; Kaye AH; Gonzales MF
    J Neurosci Res; 1994 Dec; 39(5):604-12. PubMed ID: 7534359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroscience: An ageing view of myelin repair.
    Nave KA
    Nature; 2008 Sep; 455(7212):478-9. PubMed ID: 18818646
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of CNS and PNS myelin proteins in the pathology of myelin disorders.
    Quarles RH
    J Neurol Sci; 2005 Feb; 228(2):187-9. PubMed ID: 15694201
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelin repair: developmental myelination redux?
    Balabanov R; Popko B
    Nat Neurosci; 2005 Mar; 8(3):262-4. PubMed ID: 15746910
    [No Abstract]   [Full Text] [Related]  

  • 19. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
    Coetzee T; Dupree JL; Popko B
    J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/soluble interleukin-6 receptor fusion protein.
    Zhang PL; Izrael M; Ainbinder E; Ben-Simchon L; Chebath J; Revel M
    Mol Cell Neurosci; 2006 Mar; 31(3):387-98. PubMed ID: 16325417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.